Loading…
RadioMedix and ITM's subsidiary ITG signed a manufacturing and supply agreement for the production of next-generation Ge-68/Ga-68 generators at the new RadioMedix Spica Center in Houston, Texas.
Endocyte and ITM subsidiary ITG signed a long-term global supply agreement for no-carrier-added Lutetium-177 (EndolucinBeta) to support clinical and commercial supply of 177Lu-PSMA-617 through 2035. Endocyte will pay €5 million upfront to support ITM's expansion of manufacturing capacity.